NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

22 September 2016

Five private equity groups may bid for Bayer’s dermatology business

skin-care-937667_640 PE majors KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may look into a potential $1.1bn buy of Bayer's dermatology division.

22 September 2016

Forbion reaps ‘considerable return’ from Akarna exit to Allergan

apothecary-pharmacy-chemist-mortar-and-pestle-39522 Forbion Capital Partners has gotten its money's worth from the sale of Akarna Therapeutics just seven months after investing in the company, AltAssets understands.

4 December 2015

Charterhouse eyes €600m from potential 2016 Doc Generici sale

cure-1006810_1920 UK-headquartered private equity firm Charterhouse has reportedly hired LEK Consulting to advise on options for pharmaceuticals portfolio company Doc Generici.

11 November 2015

RiverVest closes $40.5m Series C round in US Amplyx Pharmaceuticals

laboratory-829371_1920 Life sciences-focused RiverVest Venture Partners has led a $40.5m Series C round in Amplyx Pharmaceuticals, a San-Diego based developer of treatments of life-threatening fungal infections.

2 November 2015

Warburg Pincus backs Polish pharmacy chain Gemini

pharmacy-218692_1920 Global private equity major Warburg Pincus is the new partner of Apteki Gemini, the Gdansk-based pharmacy operator has announced.

8 October 2015

Genstar backs drug industry solutions provider PSKW

pills-943764_1280 Genstar Capital has made “a substantial investment” in New Jersey-based PSKW, tapping its recently closed seventh fund for the first time.

6 May 2015

RiverVest to target pharma, medical devices with new $80.2m fund

pharmaceutical-12_sq Life sciences-focused RiverVest Venture Partners plans to target the pharmaceutical and therapeutic medical device sectors after closing its third fund on just over $80m.

6 February 2015

Hercules, Capital Ten, lift heart disease researcher to $23.3m Series B

untitled-1238683-m Hercules Bioventure Partners and Capital Ten have led a $23.3m Series B round for cardiovascular drugs company Armetheon.

27 January 2015

Chinese venture firm Legend Capital leads $100m round for Innovent Biologics

china-flag-1421043-m Beijing-headquartered Legend Capital has led a $100 m Series C financing round for Chinese pharmaceuticals group Innovent Biologics. Singapore-based investment company Temasek, with S$223bn ($178 bn) in AUM also took part in the round said Innovent. PE firms already invested in Innovent include Fidelity Biosciences, Fidelity Growth Partners Asia, Lilly Asia Ventures, and Frontline Bioventures.[...]

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

Page 1 of 712345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016